Dr. Dawn Marie Gurican Dillon, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 424 Savannah Rd, Lewes, DE 19958 Phone: 302-645-3525 Fax: 302-645-3513 |
Linda Choy, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 424 Savannah Rd, Lewes, DE 19958 Phone: 302-645-3555 Fax: 302-644-3560 |
Julie A. Holmon, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 424 Savannah Rd, Lewes, DE 19958 Phone: 302-645-3555 Fax: 302-644-3560 |
News Archive
As the clock ticked down on the pending divorce of Walgreen Co. and one of its largest customers, rivals of the drugstore giant raced to woo millions of soon-to-be-displaced consumers whose medications wouldn't be covered by insurance at its stores come Jan. 1. CVS Caremark, Rite Aid and other small- to medium-size drugstores launched advertising campaigns and beefed up staff in anticipation of adding tens of millions of new prescriptions should Walgreen and Express Scripts Inc. fail to come to terms on a new contract starting in 2012.
The New York Times examines several products being studied in clinical trials that researchers hope will one day prevent sexual transmission of HIV. The newspaper describes the ongoing trials of a vaginal microbicide gel containing the antiretroviral tenofovir which was found to reduce the risk of HIV infection in women by 39 percent, writing, "[o]ther clinical trials will report their results in 2011 and 2012 and, if all goes well, researchers hope to have a product or two ready to enter the market by 2013."
Pfizer Inc. (NYSE: PFE) announced results from a new post-hoc analysis of the EMPHASIS-HF trial showing statistically significant reductions in rates of cumulative heart failure (HF) hospitalisations in patients with HF treated with eplerenone compared with placebo on a background of standard optimal therapy.1 The results were presented at The European Society of Cardiology Congress (ESC) in Munich.
According to a new study that refutes earlier evidence, stress does not appear to increase a person's risk of developing multiple sclerosis (MS). The research is published in the May 31, 2011, print issue of Neurology, the medical journal of the American Academy of Neurology.
In the laboratories of Institute of Molecular Medicine Finland, drug testing is done ex vivo. That is, various leukemia drugs are tested with patient samples instead of the patients themselves. This enables the researchers to test different drug combinations efficiently and without burdening the patient.
› Verified 9 days ago